Pharmstandard International S.A. filings

This page lists the SEC filings reported by Pharmstandard International S.A..

SEC filings by Pharmstandard International S.A. (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2018-11-15Pharmstandard International S.A.Allena Pharmaceuticals, Inc.873,0314.2%EDGAR
SC 13G/A2018-02-21Pharmstandard International S.A.Protagonist Therapeutics, Inc982,2704.8%EDGAR
SC 13G2018-02-15Pharmstandard International S.A.Allena Pharmaceuticals, Inc.1,037,2675.0%EDGAR
SC 13D/A2017-06-26Pharmstandard International S.A.ARGOS THERAPEUTICS INC18,362,88339.9%EDGAR
SC 13G2017-02-13Pharmstandard International S.A.Protagonist Therapeutics, Inc983,5705.9%EDGAR
SC 13D/A2016-10-18Pharmstandard International S.A.ARGOS THERAPEUTICS INC18,362,88339.6%EDGAR
SC 13D/A2016-08-18Pharmstandard International S.A.ARGOS THERAPEUTICS INC17,931,62438.7%EDGAR
SC 13D/A2016-07-12Pharmstandard International S.A.ARGOS THERAPEUTICS INC13,795,26141.3%EDGAR
SC 13D/A2016-05-27Pharmstandard International S.A.ARGOS THERAPEUTICS INC--EDGAR
SC 13D2016-03-22Pharmstandard International S.A.ARGOS THERAPEUTICS INC9,108,23434.2%EDGAR
SC 13G2015-02-12Pharmstandard International S.A.PROTEON THERAPEUTICS INC1,165,3447.1%EDGAR
SC 13G2015-02-12Pharmstandard International S.A.ARGOS THERAPEUTICS INC5,983,54930.4%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.